CHOP Researchers Reveal How NSAIDs Worsen C. difficile Infections
Published on
CHOP researchers have shown that NSAIDs disrupt epithelial cells in the colon and sensitize them to C. difficile toxins by perturbing cell mitochondria.
News Room
101 - 110 of 1178
CHOP Investigator Recognized for Airway Research
Published on
Children’s Hospital of Philadelphia (CHOP) researcher Riccardo Gottardi, PhD has been named a “Young Innovator of Cellular and Molecular Bioengineering” by Cellular and Molecular Bioengineering, the official journal of the Biomedical Engineering Society.
CHOP Researchers Develop Tool for Helping Predict Alzheimer’s Risk in Various Ethnic Populations
Published on
Tool may be more accurate than existing methods and was made possible through a cohort of tens of thousands of patients from different backgrounds around the world.
CHOP Treats 500th CAR T Patient
Published on
CHOP has treated its 500th patient with CAR T-cell immunotherapy, a “living drug” that harnesses the power of a patient’s own immune system to fight cancer.
Children’s Hospital of Philadelphia Recognized by the 2023 Disability Equality Index (DEI) as a Leader in “Best Places to Work for Disability Inclusion”
Published on
Children’s Hospital of Philadelphia (CHOP) has been recognized by the 2023 Disability Equality Index (DEI) as a leader in “Best Places to Work for Disability Inclusion.”
Meet Christopher Cielo, DO
Published on
Christopher Cielo, DO, joined the Division of Pulmonary and Sleep Medicine at Children’s Hospital of Philadelphia (CHOP) in 2010 and is an attending pulmonologist.
Interpersonal and Structural Stigma Toward Sexual Minority Youth Create Mental Health Challenges, Increased Suicide Risk
Published on
CHOP researchers suggest more targeted intervention against discrimination, particularly in states with higher rates of structural stigma.
Children’s Hospital of Philadelphia Receives $1 Million Grant from Pediatric Cancer Foundation
Published on
Children’s Hospital of Philadelphia (CHOP) announced it has received $1 million from Pediatric Cancer Foundation, an organization that has been raising funds for research since 1970 to support doctors and hospitals in an effort to eradicate childhood cancer. The grant will help to fund a planned first-in-human phase 1 clinical trial led by Sarah K. Tasian, MD, which will use a new immunotherapy to target the FLT3 receptor protein in high-risk pediatric leukemias.
Children’s Hospital of Philadelphia Joins KidsX, Global Leader in Pediatric Digital Health Innovation, to Amplify Digital Transformation Efforts
Published on
Children’s Hospital of Philadelphia (CHOP) has announced that the organization is now a part of KidsX, a global leader in pediatric digital health innovation. KidsX facilitates collaboration between elite children’s hospitals, providers, payors, investors, entrepreneurs, and corporate partners to solve the most pressing problems in pediatric care delivery.
CHOP Orthopaedics Named #1 in the Nation by U.S. News & World Report
Published on
U.S. News & World Report recognized CHOP’s Division of Orthopaedics as the best in the nation for 2023-24.